Navigation Links
Teslascan

ProductsTeslascan
Company Amersham Health
Item Teslascan
Features 
Description TESLASCAN is a liver-specific contrast agent approved for sale in the U.S. in November 1997. Its introduction expands the Amersham Health portfolio to include an organ-specific MR agent. When injected intravenously, TESLASCAN aids in the detection, localization, characterization, and evaluation of liver lesions. Imaging can begin within minutes of injection, and additional scans can be taken up to 24 hours later without reinjection or loss of image quality.
Info Amersham Health
Customer Service: (800) 654-0118
Web site: http://www.amershamhealth-us.com/

Related medicine products :

1. Visipaque™
Used for retrograde pyelogram. The tip configuration occludes the ureteral orifice and stabilizes the catheter by temporarily wedging in the orifice. Supplied sterile in peel-open packages. Intended ...
... for the injection of contrast medium, anesthetic ... lumen design eliminates the need for multiple ... promote atraumatic passage into and through the ... hydrophilic polymer that when activated, attracts and ...
Used for drainage and retrograde pyelogram. Supplied sterile in peel-open packages. Intended for one-time use....
... The whistle tip has two ... plastic and the Luer fitting adapter ... for identification of left or right. ... sterile and x-ray opaque. The length ...
Medicine Products:
(Date:3/29/2017)... ... 2017 , ... The Wharton School of the University of Pennsylvania is pleased ... a $10 million gift to establish the Ken Moelis and Julie Taffet Moelis ... a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand traditional ...
(Date:3/29/2017)... , ... March 29, 2017 , ... VisualSP has helped ... Until recently, the only option for on-premises installation of its Help System for SharePoint ... to install the system into the entire tenant. , The company recently released ...
(Date:3/28/2017)... ... 28, 2017 , ... Tuesday, March 28, 2017, is the annual American Diabetes ... Risk Test to find out if they are at risk for developing Type 2 ... the evening sky by programming the LAX pylons the color red. Downtown’s U.S. Bank ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati Technologies announced ... address the resolution to globally reduce the harmful use of alcohol set forth ... and TTB approved ingredients that when infused into alcohol, renders the alcohol liver ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... is pleased to be invited to the Siemens Healthineers annual customer education symposium, ... The event will take place from March 27 - 31, 2017 at the ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017 Research and Markets has announced the ... report to their offering. ... The global energy-based aesthetic devices market to grow at ... The report, Global Energy-Based Aesthetic Devices Market 2017-2021, has been prepared ... The report covers the market landscape and its growth prospects over ...
(Date:3/29/2017)... , March 29, 2017  Novartis announced ... (FDA) has accepted the company,s Biologics License Application ... (tisagenlecleucel-T), an investigational chimeric antigen receptor T cell ... and young adult patients with B-cell acute lymphoblastic ... by Novartis for a CAR-T. The priority review ...
(Date:3/29/2017)...  The Global Health Innovative Technology Fund (GHIT ... battle infectious diseases around the globe, today announced ... help deliver a range of new innovative therapies ... This latest round of targeted support includes ... a pediatric formulation of a drug considered the ...
Breaking Medicine Technology: